Cargando…

Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD)

INTRODUCTION: A 47 y.o. female patient was admitted to the female PICU with a manic episode. Upon admission she presented with mood elation, psychosis, pressured speech, lack of sleep and agitation. OBJECTIVES: To investigate negative prognostic factors such as the co-morbidity with a personality di...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarafopoulos, A., Antoniadis, D., Karpouza, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470876/
http://dx.doi.org/10.1192/j.eurpsy.2021.1662
_version_ 1784788936871116800
author Sarafopoulos, A.
Antoniadis, D.
Karpouza, V.
author_facet Sarafopoulos, A.
Antoniadis, D.
Karpouza, V.
author_sort Sarafopoulos, A.
collection PubMed
description INTRODUCTION: A 47 y.o. female patient was admitted to the female PICU with a manic episode. Upon admission she presented with mood elation, psychosis, pressured speech, lack of sleep and agitation. OBJECTIVES: To investigate negative prognostic factors such as the co-morbidity with a personality disorder in patients presenting with severe mania. METHODS: The patient was assessed regularly by the psychiatric team consisting of a CT doctor and one General Adult Consultant. Appropriate psychological assessments for mania and laboratory investigations took place. RESULTS: The patient initially scored above 45 in the Young Mania Rating Scale (YMRS), establishing a diagnosis of severe mania. She was treated with Olanzapine titrated up to 20mg OD and augmentation with Lithium treatment. Lithium plasma levels were at 0,6. Due to the treatment resistant manic presentation a second antipsychotic agent was administered and the patient was also treated with Zuclopenthixol depot 400mg every two weeks. Clinical improvement was observed after 16 days from admission. CONCLUSIONS: The clinical team wondered about the clinical challenges of the case. According to the literature having a Personality Disorder diagnosis is a negative prognostic factor for patients with mania and this is relevant to this case as well. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9470876
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94708762022-09-29 Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD) Sarafopoulos, A. Antoniadis, D. Karpouza, V. Eur Psychiatry Abstract INTRODUCTION: A 47 y.o. female patient was admitted to the female PICU with a manic episode. Upon admission she presented with mood elation, psychosis, pressured speech, lack of sleep and agitation. OBJECTIVES: To investigate negative prognostic factors such as the co-morbidity with a personality disorder in patients presenting with severe mania. METHODS: The patient was assessed regularly by the psychiatric team consisting of a CT doctor and one General Adult Consultant. Appropriate psychological assessments for mania and laboratory investigations took place. RESULTS: The patient initially scored above 45 in the Young Mania Rating Scale (YMRS), establishing a diagnosis of severe mania. She was treated with Olanzapine titrated up to 20mg OD and augmentation with Lithium treatment. Lithium plasma levels were at 0,6. Due to the treatment resistant manic presentation a second antipsychotic agent was administered and the patient was also treated with Zuclopenthixol depot 400mg every two weeks. Clinical improvement was observed after 16 days from admission. CONCLUSIONS: The clinical team wondered about the clinical challenges of the case. According to the literature having a Personality Disorder diagnosis is a negative prognostic factor for patients with mania and this is relevant to this case as well. DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9470876/ http://dx.doi.org/10.1192/j.eurpsy.2021.1662 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Sarafopoulos, A.
Antoniadis, D.
Karpouza, V.
Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD)
title Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD)
title_full Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD)
title_fullStr Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD)
title_full_unstemmed Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD)
title_short Treatment resistant manic episode with commorbidity with borderline personality disorder (BPD)
title_sort treatment resistant manic episode with commorbidity with borderline personality disorder (bpd)
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470876/
http://dx.doi.org/10.1192/j.eurpsy.2021.1662
work_keys_str_mv AT sarafopoulosa treatmentresistantmanicepisodewithcommorbiditywithborderlinepersonalitydisorderbpd
AT antoniadisd treatmentresistantmanicepisodewithcommorbiditywithborderlinepersonalitydisorderbpd
AT karpouzav treatmentresistantmanicepisodewithcommorbiditywithborderlinepersonalitydisorderbpd